As of 2026-01-08, the EV/EBITDA ratio of Utah Medical Products Inc (UTMD) is 6.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. UTMD's latest enterprise value is 100.37 mil USD. UTMD's TTM EBITDA according to its financial statements is 16.28 mil USD. Dividing these 2 quantities gives us the above UTMD EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 15.9x | 14.4x |
| Forward P/E multiples | 12.4x - 17.6x | 15.2x |
| Fair Price | 77.13 - 107.45 | 94.21 |
| Upside | 33.7% - 86.2% | 63.3% |
| Date | EV/EBITDA |
| 2026-01-06 | 6.07 |
| 2026-01-05 | 6.14 |
| 2026-01-02 | 5.93 |
| 2025-12-31 | 5.82 |
| 2025-12-30 | 5.88 |
| 2025-12-29 | 6.06 |
| 2025-12-26 | 5.98 |
| 2025-12-24 | 5.89 |
| 2025-12-23 | 6.01 |
| 2025-12-22 | 5.95 |
| 2025-12-19 | 5.95 |
| 2025-12-18 | 6.10 |
| 2025-12-17 | 6.10 |
| 2025-12-16 | 6.31 |
| 2025-12-15 | 6.12 |
| 2025-12-12 | 6.24 |
| 2025-12-11 | 6.16 |
| 2025-12-10 | 5.92 |
| 2025-12-09 | 5.76 |
| 2025-12-08 | 5.74 |
| 2025-12-05 | 5.83 |
| 2025-12-04 | 5.83 |
| 2025-12-03 | 5.76 |
| 2025-12-02 | 5.61 |
| 2025-12-01 | 5.66 |
| 2025-11-28 | 5.90 |
| 2025-11-26 | 5.76 |
| 2025-11-25 | 5.82 |
| 2025-11-24 | 5.68 |
| 2025-11-21 | 5.66 |
| 2025-11-20 | 5.40 |
| 2025-11-19 | 5.42 |
| 2025-11-18 | 5.56 |
| 2025-11-17 | 5.62 |
| 2025-11-14 | 5.71 |
| 2025-11-13 | 5.85 |
| 2025-11-12 | 5.87 |
| 2025-11-11 | 6.07 |
| 2025-11-10 | 6.08 |
| 2025-11-07 | 6.10 |
| 2025-11-06 | 6.20 |
| 2025-11-05 | 6.22 |
| 2025-11-04 | 6.27 |
| 2025-11-03 | 6.32 |
| 2025-10-31 | 6.24 |
| 2025-10-30 | 5.95 |
| 2025-10-29 | 6.03 |
| 2025-10-28 | 6.33 |
| 2025-10-27 | 6.46 |
| 2025-10-24 | 6.70 |